Applicant establishments or organisations have the equipment described in the rules of good practice provided for in article L. 1245-6, enabling them to guarantee the quality, health safety and traceability of tissues, their derivatives or cells or cell therapy preparations and to reduce the risks, particularly of contamination, for recipients and staff.